![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SHIRE IN-LICENSES DEVELOPMENT RIGHTS TO TISSUE PROTECTIVE CYTOKINE TECHNOLOGY FROM WARREN PHARMACEUTICALS
SHIRE IN-LICENSES DEVELOPMENT RIGHTS TO TISSUE PROTECTIVE CYTOKINE TECHNOLOGY FROM WARREN PHARMACEUTICALS
Shire plc announces that it has in-licensed rights to tissue protective cytokine (TPC) technology under an agreement with Warren Pharmaceuticals, Inc. The agreement gives Shire exclusive worldwide rights to develop TPCs in non-Nervous System indications, including renal and genetic disease areas.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-03-2006/0004444132&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct